ALB and Decreased liver function: Clinical outcomes were reported in both studies and showed reduced serum bilirubin and improved serum albumin 2 months following cell infusion in the first study15 and improved serum albumin and Child-Pugh score (a marker of liver dysfunction) at 6 months in the second.16 These two initial studies highlight the significant number of variables involved in comparing these and subsequent studies.